Bill > HB05482

This bill, effective January 1, 2027, mandates that individual and group health insurance policies, as well as Medicaid, must cover a twelve-month supply of prescription hormone therapy and contraceptives, which are drugs approved by the U.S. Food and Drug Administration (FDA) used to manage hormone levels, dispensed at one time, unless the patient requests a smaller amount, their prescribing provider advises it, or the medication is a controlled substance, in which case maximum allowed refills will be covered. The bill defines "prescription hormone therapy" to exclude certain diabetes medications and clarifies that health plans can still implement drug utilization management strategies and limit refills in the last quarter of a plan year if a twelve-month supply has already been dispensed.